ACP Journal Club. In at-risk patients with type 2 diabetes, saxagliptin and placebo did not differ for CV events.

Oscar L. Morey-Vargas, Victor M. Montori

Research output: Contribution to journal › Comment/debate › peer-review

Fingerprint

Dive into the research topics of 'ACP Journal Club. In at-risk patients with type 2 diabetes, saxagliptin and placebo did not differ for CV events.'. Together they form a unique fingerprint.